{"id":6340,"date":"2025-09-18T18:21:55","date_gmt":"2025-09-18T21:21:55","guid":{"rendered":"https:\/\/wctcim.cabsin.org.br\/new\/presentation\/guidelines-asco-sio-2\/"},"modified":"2025-09-19T07:22:14","modified_gmt":"2025-09-19T10:22:14","slug":"guidelines-asco-sio-2","status":"publish","type":"presentation","link":"https:\/\/wctcim.cabsin.org.br\/new\/presentation\/guidelines-asco-sio-2\/","title":{"rendered":"Guidelines ASCO SIO"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>This presentation at the 3rd WCTCIM explores the updated Guidelines ASCO SIO. The session covers evidence-based recommendations for integrating complementary therapies into conventional cancer care, focusing on improving patient outcomes and overall quality of life.<\/p>\n","protected":false},"featured_media":0,"template":"","activity-category":[221],"activity-tag":[],"activity-location":[188],"class_list":["post-6340","presentation","type-presentation","status-publish","hentry","activity-category-presentations","activity-location-room-6"],"acf":{"origem_da_ultima_atualizacao":"manual_ui","event_day":"17","start_time":"15:30","end_time":"16:00","abstract":"","presentation_speaker":[{"ID":5598,"post_author":"2","post_date":"2025-09-14 20:50:05","post_date_gmt":"2025-09-14 23:50:05","post_content":"<!-- wp:html -->\n<style>\n  .speaker-bio {\n    display: flex;\n    flex-wrap: wrap;\n    align-items: flex-start;\n    gap: 20px;\n  }\n\n  .speaker-bio figure {\n    width: 225px;\n    height: 225px;\n    margin: 0 20px 30px 0;\n  }\n  .speaker-bio figure img {\n    width: 100%;\n    height: 100%;\n    object-fit: cover;\n    border-radius: 50%;\n    border: none;\n  }\n\n  .bio-content {\n    flex: 1;\n    color: #414d58;\n    font-size: 15px;    \n    line-height: 1.6;\n  }\n  .bio-content a {\n    color: #1d89e4;\n    text-decoration: none;\n  }\n\n  .bio-content h2 {\n    font-size: 24px;\n    color: #1d89e4;\n    font-weight: 600;\n    line-height: 1.5;\n    margin-bottom: 1em;\n  }\n  .bio-content h3 {\n    font-size: 18px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.8em;\n    margin-bottom: 0.8em;\n  }\n  .bio-content h4 {\n    font-size: 15px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.5em;\n    margin-bottom: 0.6em;\n  }\n\n  .speaker-separator {\n    margin: 0;\n    border: none;\n    border-top: 1px solid #ccc;\n  }\n\n  @media (max-width: 600px) {\n    .speaker-bio {\n      flex-direction: column;\n      align-items: flex-start;\n      gap: 10px;\n    }\n    .speaker-bio figure {\n      width: 180px;\n      height: 180px;\n      margin-bottom: 10px;\n    }\n    .bio-content {\n      width: 100%;\n      text-align: left;\n    }\n    .bio-content h2 {\n      font-size: 20px;\n      line-height: 1.5;\n      margin-bottom: 0.8em;\n    }\n    .bio-content h3 {\n      font-size: 16px;\n      line-height: 1.4;\n      margin-top: 1.5em;\n      margin-bottom: 0.6em;\n    }\n    .bio-content h4 {\n      font-size: 14px;\n      line-height: 1.4;\n      margin-top: 1.3em;\n      margin-bottom: 0.5em;\n    }\n    .bio-content p,\n    .bio-content ul {\n      font-size: 14px;\n    }\n  }\n<\/style>\n<div class=\"speaker-bio\">\n  <figure>\n    <img\n      src=\"https:\/\/wctcim.cabsin.org.br\/new\/wp-content\/uploads\/2025\/09\/shannon_elizabeth_fogh__profile_2025_09_14.png\"\n      alt=\"Dr. Shannon Elizabeth Fogh, Associate Professor and researcher in integrative and radiation oncology.\"\n    \/>\n  <\/figure>\n  <div class=\"bio-content\">\n<h2>Shannon Elizabeth Fogh<\/h2>\n    <p><strong>Shannon Elizabeth Fogh<\/strong>, MD, is a distinguished radiation oncologist and integrative medicine physician. She serves as an Associate Professor at the Fred Hutch Cancer Center and the University of Washington School of Medicine. Her work focuses on merging conventional cancer treatments with evidence-based integrative therapies to improve patient outcomes and quality of life.<\/p>\n    <p>Dr. Fogh's expertise in researching and applying complementary approaches within oncology is highly relevant to the 3rd WCTCIM's goals. Consequently, her contributions provide valuable insights into creating more holistic and patient-centered cancer care models, aligning with the congress's vision for a healthier future.<\/p>\n    <p><strong>ORCID Profile:<\/strong>\n      <a href=\"https:\/\/orcid.org\/0009-0004-4776-5083\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/orcid.org\/0009-0004-4776-5083<\/a>\n    <\/p>\n  <\/div>\n<\/div>\n<hr class=\"speaker-separator\">\n<div class=\"bio-content\">\n  <h3>Biography and Expertise of Shannon Elizabeth Fogh<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh<\/strong> is a pioneering physician-scientist uniquely positioned at the intersection of radiation oncology and integrative medicine. Her dual board certifications provide her with a comprehensive perspective on cancer care, enabling her to combine high-tech radiation therapies with evidence-based complementary strategies. This integrated approach aims to manage treatment-related side effects, enhance patient well-being, and ultimately improve clinical outcomes. Her clinical practice and research are dedicated to patients with primary and metastatic brain tumors, including pediatric cases.<\/p>\n  <p>Her work directly embodies the 3rd WCTCIM's thematic axis, \"Contributions of TCIM to Global Public Health (Evidence-Based).\" Dr. Fogh's research on interventions like Manuka honey to prevent esophagitis or the role of metabolic health in cancer outcomes demonstrates a rigorous, scientific approach to validating integrative therapies. Therefore, her expertise powerfully supports the congress motto pillar of \"Well-being Societies\" by developing practical strategies that improve the quality of life for cancer survivors.<\/p>\n  <p>Furthermore, the focus of <strong>Shannon Elizabeth Fogh<\/strong> on bridging gaps between medical disciplines resonates with the WHO Traditional Medicine Strategy's emphasis on integration. Her efforts to understand the interplay between the microbiome and neurocognition in cancer patients showcase a commitment to exploring complex systems, a hallmark of both integrative and traditional medicine. This forward-thinking research provides a model for how knowledge diversity can lead to more effective and humane healthcare.<\/p>\n  <\/div>\n<div class=\"bio-content\">\n  <h3>Professional Career<\/h3>\n  <p>The career of Dr. <strong>Shannon Elizabeth Fogh<\/strong> reflects a commitment to advancing cancer care through clinical excellence and research. As an Associate Professor at two prestigious institutions, the Fred Hutch Cancer Center and the University of Washington School of Medicine, she educates future physicians and scientists. Her career is characterized by a consistent effort to build bridges between conventional oncology and the growing field of evidence-based integrative medicine.<\/p>\n  <p>Her leadership roles extend beyond clinical practice, developing programs that support patients throughout their cancer journey. This blend of patient care, research, and program development positions her as a leader in creating more comprehensive and supportive oncology services. Consequently, her experience provides a valuable blueprint for integrating TCIM into complex hospital systems.<\/p>\n  <ul>\n    <li><strong>Associate Professor:<\/strong> Currently holds this academic rank at Fred Hutch Cancer Center and the University of Washington School of Medicine, where she is involved in clinical care, research, and teaching.<\/li>\n    <li><strong>CNS Radiation Oncologist:<\/strong> Specializes in treating central nervous system tumors, including primary and metastatic brain tumors in both adult and pediatric populations, using advanced radiation techniques.<\/li>\n    <li><strong>Integrative Oncologist:<\/strong> Provides evidence-based integrative medicine consultations and therapies to help cancer patients manage symptoms, reduce side effects, and improve their overall quality of life.<\/li>\n    <li><strong>Faculty Lead of Integrative Approaches to Brain Cancer Survivorship:<\/strong> Responsible for guiding and developing programs that address the long-term needs of brain cancer survivors, integrating complementary therapies into their follow-up care.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Academic Qualifications<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh<\/strong>'s academic and professional qualifications are a testament to her expertise in two distinct yet complementary fields of medicine. Her foundational training in radiation oncology provides her with the technical and clinical skills to manage complex cancers using state-of-the-art technology. This rigorous training is the bedrock of her identity as a cancer specialist, ensuring the highest standards of conventional care for her patients.<\/p>\n  <p>Building upon this foundation, her additional board certification in integrative medicine represents a deliberate expansion of her clinical toolkit. This dual certification is relatively rare and signifies a commitment to a more holistic, patient-centered model of care. Therefore, it equips Dr. Fogh with the knowledge to critically evaluate and safely incorporate non-conventional therapies, ensuring they are used as part of a cohesive and evidence-informed treatment plan. This unique combination of qualifications makes her a vital resource in the evolving landscape of oncology.<\/p>\n  <ul>\n    <li><strong>Board-Certified in Radiation Oncology:<\/strong> This certification, awarded by the American Board of Radiology, represents the highest standard of competence in the use of radiation to treat cancer and other diseases.<\/li>\n    <li><strong>Board-Certified in Integrative Medicine:<\/strong> This certification, awarded by the American Board of Integrative Medicine (ABOIM), recognizes physicians who have demonstrated mastery of evidence-based integrative medicine, focusing on holistic, patient-centered care.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Research and Publications from Shannon Elizabeth Fogh<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh's<\/strong> research is extensive, with over 67 peer-reviewed publications and book chapters. Her work centers on clinically relevant questions to improve the patient experience during and after cancer treatment. A landmark achievement was her role in designing and leading the national cooperative group study RTOG 1012. This trial investigated Manuka honey for preventing radiation-induced esophagitis in lung cancer patients, setting a precedent by incorporating an integrative therapy into a large-scale, multi-institutional study and using patient-reported outcomes as a primary endpoint.<\/p>\n  <p>Her current research explores the frontiers of integrative oncology. Dr. Fogh is investigating the critical interplay between metabolic health, such as glucose levels, and the microbiome on cancer outcomes. Beyond that, she focuses on treatment-related symptoms like fatigue and neurocognitive deficits, often called \"chemo brain.\" This research is crucial for developing interventions that can mitigate the long-term consequences of cancer therapy.<\/p>\n  <h4>Selected Publications Highlighting Her Work:<\/h4>\n  <ul>\n    <li>Her early work on hypofractionated stereotactic radiotherapy for recurrent gliomas, published in journals like the <em>Journal of Clinical Oncology<\/em>, established her expertise in advanced radiation techniques for challenging brain tumors.<\/li>\n    <li>A 2014 publication in <em>Seminars in Radiation Oncology<\/em> focused on the importance of standardization and quality assurance in radiation therapy for high-grade gliomas, underscoring her commitment to precision and safety in clinical practice.<\/li>\n    <li>More recently, a 2021 clinical debate in <em>Neuro-Oncology Practice<\/em> explored treatment decisions for oligodendroglioma, showcasing her thought leadership in neuro-oncology.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Research Grants and Recognition<\/h3>\n  <p>The innovative research led by Dr. <strong>Shannon Elizabeth Fogh<\/strong> has attracted competitive funding from prestigious foundations and research hubs, a clear recognition of her work's potential to impact patient care. Securing these grants underscores the scientific merit and clinical relevance of her investigations into integrative oncology. This peer-reviewed funding is a significant form of acknowledgment from the scientific community, enabling her to pursue novel questions that bridge conventional and complementary medicine.<\/p>\n  <p>These grants allow her to conduct pilot and feasibility studies that are essential for gathering the preliminary data needed for larger, definitive trials. Consequently, this support is critical for translating promising ideas from the laboratory and clinic into evidence-based practices that can benefit patients globally.<\/p>\n  <ul>\n    <li><strong>Kuni Foundation Grant ($99,738):<\/strong> Awarded for a pilot and feasibility study titled \"The Impact of Glucose on Primary Brain Tumor Prognosis.\" This project investigates the crucial link between metabolic health and brain tumor outcomes.<\/li>\n    <li><strong>HDFCCC Integrative Oncology Research Hub RFA:<\/strong> As Principal Investigator (PI), Dr. Fogh received funding to support \"Integrative Cancer Care for Brain Tumor Patients,\" a project aimed at developing and implementing holistic care models for this specific patient population.<\/li>\n    <li><strong>HDFCCC Integrative Oncology Research Hub RFA:<\/strong> As Co-Principal Investigator, she contributed to a project on \"Qualitative Research in Integrative Oncology Group Medical Visits,\" focusing on the implementation and efficacy of group-based integrative care.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Program Leadership and Development<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh<\/strong> has demonstrated significant leadership in developing and guiding clinical programs that directly benefit cancer patients. Her role as the Faculty Lead of Integrative Approaches to Brain Cancer Survivorship highlights a deep commitment to patient care that extends far beyond the initial phase of treatment. Survivorship is a critical and often overlooked aspect of the cancer journey, encompassing long-term physical, emotional, and cognitive challenges.<\/p>\n  <p>By leading this initiative, Dr. Fogh has been instrumental in creating a structured, supportive environment where survivors can access evidence-based integrative therapies to manage these long-term effects. This work involves strategic planning, collaboration with a multidisciplinary team of healthcare professionals, and a focus on improving the overall quality of life for patients. Therefore, her leadership in this area serves as a model for how health systems can effectively integrate TCIM into standard oncology care pathways, ensuring that patients are supported holistically throughout their recovery.<\/p>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Connect with Dr. Fogh<\/h3>\n  <p>To further explore the research, clinical work, and publications of Dr. <strong>Shannon Elizabeth Fogh<\/strong>, please refer to her official professional profiles. These resources offer detailed information on her contributions to the fields of radiation oncology and integrative medicine.<\/p>\n  <p>\n    <strong>Official Profile at Fred Hutch Cancer Center:<\/strong>\n    <a href=\"https:\/\/www.fredhutch.org\/en\/faculty-lab-directory\/fogh-shannon.html\" target=\"_blank\" rel=\"noopener noreferrer\">View Professional Profile<\/a>\n  <\/p>\n  <p>\n    <strong>University of Washington Medicine Profile:<\/strong>\n    <a href=\"https:\/\/radonc.uw.edu\/profile\/shannon-fogh\/\" target=\"_blank\" rel=\"noopener noreferrer\">View Faculty Profile<\/a>\n  <\/p>\n<\/div>\n<!-- \/wp:html -->","post_title":"Shannon Elizabeth Fogh","post_excerpt":"Dr. Shannon Elizabeth Fogh is a dual board-certified physician in radiation oncology and integrative medicine. Her work bridges these fields to improve outcomes and reduce treatment toxicity for cancer patients, with research focused on brain tumors, metabolic health, and the microbiome.","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"shannon-elizabeth-fogh","to_ping":"","pinged":"","post_modified":"2025-09-29 09:40:56","post_modified_gmt":"2025-09-29 12:40:56","post_content_filtered":"","post_parent":0,"guid":"https:\/\/wctcim.cabsin.org.br\/new\/speaker\/shannon-elizabeth-fogh\/","menu_order":0,"post_type":"speaker","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":5577,"post_author":"2","post_date":"2025-09-14 20:49:49","post_date_gmt":"2025-09-14 23:49:49","post_content":"<!-- wp:html -->\n<style>\n  .speaker-bio {\n    display: flex;\n    flex-wrap: wrap;\n    align-items: flex-start;\n    gap: 20px;\n  }\n\n  .speaker-bio figure {\n    width: 225px;\n    height: 225px;\n    margin: 0 20px 30px 0;\n  }\n  .speaker-bio figure img {\n    width: 100%;\n    height: 100%;\n    object-fit: cover;\n    border-radius: 50%;\n    border: none;\n  }\n\n  .bio-content {\n    flex: 1;\n    color: #414d58;\n    font-size: 15px;    \n    line-height: 1.6;\n  }\n  .bio-content a {\n    color: #1d89e4;\n    text-decoration: none;\n  }\n\n  .bio-content h2 {\n    font-size: 24px;\n    color: #1d89e4;\n    font-weight: 600;\n    line-height: 1.5;\n    margin-bottom: 1em;\n  }\n  .bio-content h3 {\n    font-size: 18px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.8em;\n    margin-bottom: 0.8em;\n  }\n  .bio-content h4 {\n    font-size: 15px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.5em;\n    margin-bottom: 0.6em;\n  }\n\n  .speaker-separator {\n    margin: 0;\n    border: none;\n    border-top: 1px solid #ccc;\n  }\n\n  @media (max-width: 600px) {\n    .speaker-bio {\n      flex-direction: column;\n      align-items: flex-start;\n      gap: 10px;\n    }\n    .speaker-bio figure {\n      width: 180px;\n      height: 180px;\n      margin-bottom: 10px;\n    }\n    .bio-content {\n      width: 100%;\n      text-align: left;\n    }\n    .bio-content h2 {\n      font-size: 20px;\n      line-height: 1.5;\n      margin-bottom: 0.8em;\n    }\n    .bio-content h3 {\n      font-size: 16px;\n      line-height: 1.4;\n      margin-top: 1.5em;\n      margin-bottom: 0.6em;\n    }\n    .bio-content h4 {\n      font-size: 14px;\n      line-height: 1.4;\n      margin-top: 1.3em;\n      margin-bottom: 0.5em;\n    }\n    .bio-content p,\n    .bio-content ul {\n      font-size: 14px;\n    }\n  }\n<\/style>\n<div class=\"speaker-bio\">\n  <figure>\n    <img\n      src=\"https:\/\/wctcim.cabsin.org.br\/new\/wp-content\/uploads\/2025\/09\/carla_kuon_profile_2025_09_14.png\"\n      alt=\"Dr. Carla Kuon, Associate Professor of Clinical Medicine at UCSF\"\n    \/>\n  <\/figure>\n  <div class=\"bio-content\">\n    <h2>Carla Kuon, MD<\/h2>\n    <p><strong>Dr. Carla Kuon<\/strong> is an Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF) and a key physician at the UCSF Osher Center for Integrative Health. She serves as the Director of the OPTIMAL Long COVID Clinic, where she pioneers integrative approaches to complex chronic conditions. Her work bridges conventional internal medicine with evidence-based complementary therapies, focusing on integrative oncology and microbiome medicine.<\/p>\n    <p>Her clinical leadership and research directly support the 3rd WCTCIM's goal of integrating traditional and complementary medicine into global public health systems, offering valuable insights into treating post-viral syndromes.<\/p>\n    <p><strong>ORCID Profile:<\/strong>\n      <a href=\"https:\/\/orcid.org\/0000-0003-0723-3803\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/orcid.org\/0000-0003-0723-3803<\/a>\n    <\/p>\n  <\/div>\n<\/div>\n<hr class=\"speaker-separator\">\n<div class=\"bio-content\">\n  <h3>Biography and Expertise of Carla Kuon<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong> is a distinguished clinician and academic at the forefront of integrative medicine in the United States. As an Associate Professor at the University of California, San Francisco (UCSF), she has cultivated a unique career path that merges the rigors of internal medicine and hospitalist care with the holistic principles of integrative oncology and microbiome science. This dual expertise allows her to manage complex medical cases with a comprehensive toolkit that includes both conventional treatments and evidence-based complementary therapies.<\/p>\n  <p>Her work is deeply aligned with the 3rd WCTCIM's thematic axis, \"Contributions of TCIM to Global Public Health (Evidence-Based).\" Dr. Kuon's leadership of the OPTIMAL Long COVID Clinic exemplifies this, as she addresses one of the most significant public health challenges of our time through an integrative lens. Consequently, she utilizes holistic methods, including diet and nutraceuticals, to manage a condition that often eludes conventional treatment paradigms. This approach embodies the congress motto of promoting \"Knowledge Diversity\" for \"Well-being Societies.\"<\/p>\n  <p>Furthermore, the work of Dr. <strong>Carla Kuon<\/strong> in functional immunology and the management of functional gut disorders demonstrates a commitment to understanding the root causes of chronic illness. Her research and clinical practice are guided by the principles of the Gujarat Declaration, emphasizing science and evidence to validate and scale integrative health solutions. Her pioneering efforts provide a powerful model for the \"Integration of TCIM into Health Systems,\" showcasing how specialized clinics can collaborate with mainstream departments like pulmonary medicine to deliver superior patient outcomes.<\/p>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Professional Career<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong>'s career reflects a progression from a dedicated hospitalist to a leader in academic integrative medicine. She began in internal medicine, honing her skills in acute patient care. For over a decade, she served as a hospitalist, gaining experience with complex cases, including as an oncologic hospitalist on the UCSF bone marrow transplant service.<\/p>\n  <p>This clinical experience was the bedrock for her innovations. A pivotal moment was creating the inpatient hematology massage service at UCSF, a program she conceived, funded, and directs. This initiative shows her commitment to integrating patient-centered therapies to alleviate pain and anxiety. It was a step toward building institutional infrastructure for integrative care. Her career shows an evolution toward leadership roles shaping medicine's future.<\/p>\n  <ul>\n    <li><strong>2023 - Present:<\/strong> Director, OPTIMAL-IH Long COVID Clinic, UCSF, leading a nationally recognized clinic for post-viral care.<\/li>\n    <li><strong>2017 - Present:<\/strong> HS Associate Professor, Integrative Medicine, OSHER center, UCSF, where she teaches and provides clinical care.<\/li>\n    <li><strong>2017 - Present:<\/strong> Director, BMT Adult Massage Services, UCSF, overseeing a unique service for oncology patients.<\/li>\n    <li><strong>2013 - 2017:<\/strong> HS Assistant Professor, Hospitalist, Medicine, UCSF, contributing to academic hospital medicine.<\/li>\n    <li><strong>2010 - 2013:<\/strong> HS Clinical Instructor, Hospitalist, Medicine, UCSF, beginning her academic career at UCSF.<\/li>\n    <li><strong>2005 - 2013:<\/strong> Served as a Hospitalist in Internal Medicine at various institutions, including St. Helena Medical Center, TEAMHEALTH, and Galen Physicians, building a strong foundation in clinical practice.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Academic Qualifications<\/h3>\n  <p>The academic foundation of Dr. <strong>Carla Kuon<\/strong> is distinguished by its interdisciplinary nature, combining a strong background in the humanities with rigorous medical and scientific training. This unique blend provides her with a multifaceted perspective on patient care, communication, and health systems. Her education began with a Bachelor of Arts in Spanish and Portuguese Linguistics from the University of California, Los Angeles (UCLA), an experience that cultivated deep cultural and communicative competencies.<\/p>\n  <p>Following her undergraduate studies, she pursued her medical degree, residency, and a specialized fellowship that solidified her expertise in both conventional and integrative medicine. This comprehensive training pathway equipped her to not only practice medicine effectively but also to question existing paradigms and innovate new models of care. Consequently, her academic journey reflects a deliberate effort to build a skill set capable of addressing the complex, multifactorial nature of modern chronic diseases.<\/p>\n  <ul>\n    <li><strong>2018:<\/strong> Fellowship in Integrative Medicine, UCSF Osher Center, where she specialized in holistic and evidence-based complementary practices.<\/li>\n    <li><strong>2004:<\/strong> Residency in Medicine, TUFTS Medical Center, Boston, completing her postgraduate clinical training in internal medicine.<\/li>\n    <li><strong>2002:<\/strong> Internship in Medicine, TUFTS-Saint Elizabeth's Medical Center, Boston, marking her initial year of postgraduate training.<\/li>\n    <li><strong>2001:<\/strong> Doctor of Medicine (M.D.), University of Texas, San Antonio, where she earned her medical degree.<\/li>\n    <li><strong>1995:<\/strong> Bachelor of Arts (B.A.) in Spanish and Portuguese Linguistics, University of California, Los Angeles, graduating with Dean's Honors.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Research and Publications of Carla Kuon<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong> is not only a master clinician but also a dedicated scholar and author who contributes actively to the scientific literature. Her research is centered on improving patient care through integrative methods, with a significant focus on Long COVID and microbiome health. Her most prominent research involvement is as a collaborating investigator on a major grant from the National Institutes of Health (NIH) Agency for Healthcare Research and Quality (AHRQ). This five-year project aims to expand the UCSF Long COVID OPTIMAL clinic program, focusing on enhancing access and equity for underserved and minority populations.<\/p>\n  <p>This NIH-funded work is crucial because it uses an implementation science framework to scale up a successful integrative care model. It seeks to identify and overcome barriers to ensure the sustainability of comprehensive Long COVID care, directly aligning with the WHO's strategy of embedding traditional and complementary medicine into public health infrastructure. Beyond this grant, Dr. <strong>Carla Kuon<\/strong> has published articles on managing C. Difficile in oncology patients, showcasing her expertise in gut health within complex medical settings.<\/p>\n  <p>Furthermore, she translated her clinical expertise into a practical guide for the public by authoring the book, \"The Long COVID Solution,\" which outlines a holistic approach to recovery. This publication extends her impact beyond the clinic, empowering patients with knowledge and self-care strategies. Her scholarly activities demonstrate a clear commitment to building and disseminating an evidence base for integrative medicine.<\/p>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Awards and Recognitions<\/h3>\n  <p>The clinical excellence and innovative contributions of Dr. <strong>Carla Kuon<\/strong> have been formally recognized through numerous awards and honors throughout her academic and professional career. These accolades highlight her dedication to patient care, her leadership in developing new clinical programs, and her standing as a respected expert within one of the world's leading medical institutions. These recognitions underscore the impact of her work in advancing integrative medicine.<\/p>\n  <p>Her most recent honors, including a Master Clinician nomination and the UCSF Interprofessional Collaboration Award for the OPTIMAL Clinic, are particularly significant. They acknowledge not only her individual skill but also her success in fostering collaborative, team-based care models, which are essential for the successful integration of TCIM into complex healthcare systems. Consequently, these awards validate her approach and serve as an inspiration for the broader medical community.<\/p>\n  <ul>\n    <li><strong>2024:<\/strong> UCSF Interprofessional Collaboration Award, OPTIMAL Clinic, recognizing the clinic's successful multidisciplinary approach.<\/li>\n    <li><strong>2024:<\/strong> Master Clinician Nomination, acknowledging her exceptional clinical skills and patient care.<\/li>\n    <li><strong>2001:<\/strong> John Primono Humanitarian Award, University of Texas, San Antonio, highlighting her compassionate approach to medicine early in her career.<\/li>\n    <li><strong>1997:<\/strong> National Hispanic Scholarship Award, from the National Hispanic Scholarship Association.<\/li>\n    <li><strong>1995:<\/strong> Deans Honors, UCLA, for outstanding academic achievement.<\/li>\n    <li><strong>1993:<\/strong> Del Amo Scholarship and Alumni Scholarship, UCLA, recognizing her academic promise.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Board and Committee Activities<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong> demonstrates her commitment to advancing medicine through active participation in several leading professional organizations. Her memberships reflect her dual expertise, spanning conventional, preventative, and integrative medicine. This involvement ensures she remains at the cutting edge of developments in her fields and contributes her unique perspective to the broader medical community.<\/p>\n  <p>Her engagement with these societies is vital for fostering professional networks, shaping clinical standards, and advocating for patient-centered care. For instance, her membership in the Benioff Center for Microbiome Medicine places her within an elite group of researchers exploring one of the most exciting frontiers in science. Therefore, these activities are integral to her role as a leader and innovator.<\/p>\n  <ul>\n    <li><strong>2022 - Present:<\/strong> Member, Benioff Center for Microbiome Medicine<\/li>\n    <li><strong>2018 - Present:<\/strong> Member, American Board of Preventative Medicine<\/li>\n    <li><strong>2016 - Present:<\/strong> Member, Society of Hospital Medicine<\/li>\n    <li><strong>2008 - Present:<\/strong> Member, American Board of Internal Medicine<\/li>\n    <li><strong>2001 - Present:<\/strong> Member, American College of Physicians<\/li>\n    <li><strong>2001 - 2010:<\/strong> Member, Peruvian American Medical Society<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Connect with Dr. Kuon<\/h3>\n  <p>To further explore the work of Dr. <strong>Carla Kuon<\/strong>, including her clinical practice at the UCSF Osher Center for Integrative Health and her academic contributions, please visit her official university profiles. These resources provide detailed information on her expertise, research, and publications.<\/p>\n  <p>\n    <strong>Official Profile at UCSF Osher Center for Integrative Health:<\/strong>\n    <a href=\"https:\/\/osher.ucsf.edu\/patient-care\/our-team\/carla-kuon-md\" target=\"_blank\" rel=\"noopener noreferrer\">View Professional Profile<\/a>\n  <\/p>\n  <p>\n    <strong>Academic Profile at UCSF Profiles:<\/strong>\n    <a href=\"https:\/\/profiles.ucsf.edu\/carla.kuon\" target=\"_blank\" rel=\"noopener noreferrer\">View Academic and Research Profile<\/a>\n  <\/p>\n<\/div>\n<!-- \/wp:html -->","post_title":"Carla Kuon","post_excerpt":"Carla Kuon is an Associate Professor at UCSF and an Integrative Oncologist. She directs the NIH-funded OPTIMAL Long COVID clinic, applying holistic methods to complex conditions. Dr. Kuon authored a book on Long COVID recovery and leads research in functional immunology and microbiome medicine.","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"carla-kuon","to_ping":"","pinged":"","post_modified":"2025-09-29 06:04:07","post_modified_gmt":"2025-09-29 09:04:07","post_content_filtered":"","post_parent":0,"guid":"https:\/\/wctcim.cabsin.org.br\/new\/speaker\/carla-kuon\/","menu_order":0,"post_type":"speaker","post_mime_type":"","comment_count":"0","filter":"raw"}],"activity":{"ID":6273,"post_author":"2","post_date":"2025-09-18 18:21:54","post_date_gmt":"2025-09-18 21:21:54","post_content":"","post_title":"Workshop \u2758 The Role Of The Microbiome In Cancer","post_excerpt":"This workshop at the 3rd WCTCIM explores the intricate relationship of the Microbiome In Cancer. Participants will engage in a practical session to gain hands-on knowledge from experts on how gut health influences oncology and integrative treatment approaches for better patient outcomes.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"microbiome-in-cancer","to_ping":"","pinged":"","post_modified":"2025-10-12 20:37:08","post_modified_gmt":"2025-10-12 23:37:08","post_content_filtered":"","post_parent":0,"guid":"https:\/\/wctcim.cabsin.org.br\/new\/activity\/microbiome-in-cancer\/","menu_order":0,"post_type":"activity","post_mime_type":"","comment_count":"0","filter":"raw"}},"presentation_fields":{"event_day":"17","start_time":"15:30","end_time":"16:00","abstract":"","presentation_speaker":[{"ID":5598,"post_author":"2","post_date":"2025-09-14 20:50:05","post_date_gmt":"2025-09-14 23:50:05","post_content":"<!-- wp:html -->\n<style>\n  .speaker-bio {\n    display: flex;\n    flex-wrap: wrap;\n    align-items: flex-start;\n    gap: 20px;\n  }\n\n  .speaker-bio figure {\n    width: 225px;\n    height: 225px;\n    margin: 0 20px 30px 0;\n  }\n  .speaker-bio figure img {\n    width: 100%;\n    height: 100%;\n    object-fit: cover;\n    border-radius: 50%;\n    border: none;\n  }\n\n  .bio-content {\n    flex: 1;\n    color: #414d58;\n    font-size: 15px;    \n    line-height: 1.6;\n  }\n  .bio-content a {\n    color: #1d89e4;\n    text-decoration: none;\n  }\n\n  .bio-content h2 {\n    font-size: 24px;\n    color: #1d89e4;\n    font-weight: 600;\n    line-height: 1.5;\n    margin-bottom: 1em;\n  }\n  .bio-content h3 {\n    font-size: 18px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.8em;\n    margin-bottom: 0.8em;\n  }\n  .bio-content h4 {\n    font-size: 15px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.5em;\n    margin-bottom: 0.6em;\n  }\n\n  .speaker-separator {\n    margin: 0;\n    border: none;\n    border-top: 1px solid #ccc;\n  }\n\n  @media (max-width: 600px) {\n    .speaker-bio {\n      flex-direction: column;\n      align-items: flex-start;\n      gap: 10px;\n    }\n    .speaker-bio figure {\n      width: 180px;\n      height: 180px;\n      margin-bottom: 10px;\n    }\n    .bio-content {\n      width: 100%;\n      text-align: left;\n    }\n    .bio-content h2 {\n      font-size: 20px;\n      line-height: 1.5;\n      margin-bottom: 0.8em;\n    }\n    .bio-content h3 {\n      font-size: 16px;\n      line-height: 1.4;\n      margin-top: 1.5em;\n      margin-bottom: 0.6em;\n    }\n    .bio-content h4 {\n      font-size: 14px;\n      line-height: 1.4;\n      margin-top: 1.3em;\n      margin-bottom: 0.5em;\n    }\n    .bio-content p,\n    .bio-content ul {\n      font-size: 14px;\n    }\n  }\n<\/style>\n<div class=\"speaker-bio\">\n  <figure>\n    <img\n      src=\"https:\/\/wctcim.cabsin.org.br\/new\/wp-content\/uploads\/2025\/09\/shannon_elizabeth_fogh__profile_2025_09_14.png\"\n      alt=\"Dr. Shannon Elizabeth Fogh, Associate Professor and researcher in integrative and radiation oncology.\"\n    \/>\n  <\/figure>\n  <div class=\"bio-content\">\n<h2>Shannon Elizabeth Fogh<\/h2>\n    <p><strong>Shannon Elizabeth Fogh<\/strong>, MD, is a distinguished radiation oncologist and integrative medicine physician. She serves as an Associate Professor at the Fred Hutch Cancer Center and the University of Washington School of Medicine. Her work focuses on merging conventional cancer treatments with evidence-based integrative therapies to improve patient outcomes and quality of life.<\/p>\n    <p>Dr. Fogh's expertise in researching and applying complementary approaches within oncology is highly relevant to the 3rd WCTCIM's goals. Consequently, her contributions provide valuable insights into creating more holistic and patient-centered cancer care models, aligning with the congress's vision for a healthier future.<\/p>\n    <p><strong>ORCID Profile:<\/strong>\n      <a href=\"https:\/\/orcid.org\/0009-0004-4776-5083\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/orcid.org\/0009-0004-4776-5083<\/a>\n    <\/p>\n  <\/div>\n<\/div>\n<hr class=\"speaker-separator\">\n<div class=\"bio-content\">\n  <h3>Biography and Expertise of Shannon Elizabeth Fogh<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh<\/strong> is a pioneering physician-scientist uniquely positioned at the intersection of radiation oncology and integrative medicine. Her dual board certifications provide her with a comprehensive perspective on cancer care, enabling her to combine high-tech radiation therapies with evidence-based complementary strategies. This integrated approach aims to manage treatment-related side effects, enhance patient well-being, and ultimately improve clinical outcomes. Her clinical practice and research are dedicated to patients with primary and metastatic brain tumors, including pediatric cases.<\/p>\n  <p>Her work directly embodies the 3rd WCTCIM's thematic axis, \"Contributions of TCIM to Global Public Health (Evidence-Based).\" Dr. Fogh's research on interventions like Manuka honey to prevent esophagitis or the role of metabolic health in cancer outcomes demonstrates a rigorous, scientific approach to validating integrative therapies. Therefore, her expertise powerfully supports the congress motto pillar of \"Well-being Societies\" by developing practical strategies that improve the quality of life for cancer survivors.<\/p>\n  <p>Furthermore, the focus of <strong>Shannon Elizabeth Fogh<\/strong> on bridging gaps between medical disciplines resonates with the WHO Traditional Medicine Strategy's emphasis on integration. Her efforts to understand the interplay between the microbiome and neurocognition in cancer patients showcase a commitment to exploring complex systems, a hallmark of both integrative and traditional medicine. This forward-thinking research provides a model for how knowledge diversity can lead to more effective and humane healthcare.<\/p>\n  <\/div>\n<div class=\"bio-content\">\n  <h3>Professional Career<\/h3>\n  <p>The career of Dr. <strong>Shannon Elizabeth Fogh<\/strong> reflects a commitment to advancing cancer care through clinical excellence and research. As an Associate Professor at two prestigious institutions, the Fred Hutch Cancer Center and the University of Washington School of Medicine, she educates future physicians and scientists. Her career is characterized by a consistent effort to build bridges between conventional oncology and the growing field of evidence-based integrative medicine.<\/p>\n  <p>Her leadership roles extend beyond clinical practice, developing programs that support patients throughout their cancer journey. This blend of patient care, research, and program development positions her as a leader in creating more comprehensive and supportive oncology services. Consequently, her experience provides a valuable blueprint for integrating TCIM into complex hospital systems.<\/p>\n  <ul>\n    <li><strong>Associate Professor:<\/strong> Currently holds this academic rank at Fred Hutch Cancer Center and the University of Washington School of Medicine, where she is involved in clinical care, research, and teaching.<\/li>\n    <li><strong>CNS Radiation Oncologist:<\/strong> Specializes in treating central nervous system tumors, including primary and metastatic brain tumors in both adult and pediatric populations, using advanced radiation techniques.<\/li>\n    <li><strong>Integrative Oncologist:<\/strong> Provides evidence-based integrative medicine consultations and therapies to help cancer patients manage symptoms, reduce side effects, and improve their overall quality of life.<\/li>\n    <li><strong>Faculty Lead of Integrative Approaches to Brain Cancer Survivorship:<\/strong> Responsible for guiding and developing programs that address the long-term needs of brain cancer survivors, integrating complementary therapies into their follow-up care.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Academic Qualifications<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh<\/strong>'s academic and professional qualifications are a testament to her expertise in two distinct yet complementary fields of medicine. Her foundational training in radiation oncology provides her with the technical and clinical skills to manage complex cancers using state-of-the-art technology. This rigorous training is the bedrock of her identity as a cancer specialist, ensuring the highest standards of conventional care for her patients.<\/p>\n  <p>Building upon this foundation, her additional board certification in integrative medicine represents a deliberate expansion of her clinical toolkit. This dual certification is relatively rare and signifies a commitment to a more holistic, patient-centered model of care. Therefore, it equips Dr. Fogh with the knowledge to critically evaluate and safely incorporate non-conventional therapies, ensuring they are used as part of a cohesive and evidence-informed treatment plan. This unique combination of qualifications makes her a vital resource in the evolving landscape of oncology.<\/p>\n  <ul>\n    <li><strong>Board-Certified in Radiation Oncology:<\/strong> This certification, awarded by the American Board of Radiology, represents the highest standard of competence in the use of radiation to treat cancer and other diseases.<\/li>\n    <li><strong>Board-Certified in Integrative Medicine:<\/strong> This certification, awarded by the American Board of Integrative Medicine (ABOIM), recognizes physicians who have demonstrated mastery of evidence-based integrative medicine, focusing on holistic, patient-centered care.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Research and Publications from Shannon Elizabeth Fogh<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh's<\/strong> research is extensive, with over 67 peer-reviewed publications and book chapters. Her work centers on clinically relevant questions to improve the patient experience during and after cancer treatment. A landmark achievement was her role in designing and leading the national cooperative group study RTOG 1012. This trial investigated Manuka honey for preventing radiation-induced esophagitis in lung cancer patients, setting a precedent by incorporating an integrative therapy into a large-scale, multi-institutional study and using patient-reported outcomes as a primary endpoint.<\/p>\n  <p>Her current research explores the frontiers of integrative oncology. Dr. Fogh is investigating the critical interplay between metabolic health, such as glucose levels, and the microbiome on cancer outcomes. Beyond that, she focuses on treatment-related symptoms like fatigue and neurocognitive deficits, often called \"chemo brain.\" This research is crucial for developing interventions that can mitigate the long-term consequences of cancer therapy.<\/p>\n  <h4>Selected Publications Highlighting Her Work:<\/h4>\n  <ul>\n    <li>Her early work on hypofractionated stereotactic radiotherapy for recurrent gliomas, published in journals like the <em>Journal of Clinical Oncology<\/em>, established her expertise in advanced radiation techniques for challenging brain tumors.<\/li>\n    <li>A 2014 publication in <em>Seminars in Radiation Oncology<\/em> focused on the importance of standardization and quality assurance in radiation therapy for high-grade gliomas, underscoring her commitment to precision and safety in clinical practice.<\/li>\n    <li>More recently, a 2021 clinical debate in <em>Neuro-Oncology Practice<\/em> explored treatment decisions for oligodendroglioma, showcasing her thought leadership in neuro-oncology.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Research Grants and Recognition<\/h3>\n  <p>The innovative research led by Dr. <strong>Shannon Elizabeth Fogh<\/strong> has attracted competitive funding from prestigious foundations and research hubs, a clear recognition of her work's potential to impact patient care. Securing these grants underscores the scientific merit and clinical relevance of her investigations into integrative oncology. This peer-reviewed funding is a significant form of acknowledgment from the scientific community, enabling her to pursue novel questions that bridge conventional and complementary medicine.<\/p>\n  <p>These grants allow her to conduct pilot and feasibility studies that are essential for gathering the preliminary data needed for larger, definitive trials. Consequently, this support is critical for translating promising ideas from the laboratory and clinic into evidence-based practices that can benefit patients globally.<\/p>\n  <ul>\n    <li><strong>Kuni Foundation Grant ($99,738):<\/strong> Awarded for a pilot and feasibility study titled \"The Impact of Glucose on Primary Brain Tumor Prognosis.\" This project investigates the crucial link between metabolic health and brain tumor outcomes.<\/li>\n    <li><strong>HDFCCC Integrative Oncology Research Hub RFA:<\/strong> As Principal Investigator (PI), Dr. Fogh received funding to support \"Integrative Cancer Care for Brain Tumor Patients,\" a project aimed at developing and implementing holistic care models for this specific patient population.<\/li>\n    <li><strong>HDFCCC Integrative Oncology Research Hub RFA:<\/strong> As Co-Principal Investigator, she contributed to a project on \"Qualitative Research in Integrative Oncology Group Medical Visits,\" focusing on the implementation and efficacy of group-based integrative care.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Program Leadership and Development<\/h3>\n  <p>Dr. <strong>Shannon Elizabeth Fogh<\/strong> has demonstrated significant leadership in developing and guiding clinical programs that directly benefit cancer patients. Her role as the Faculty Lead of Integrative Approaches to Brain Cancer Survivorship highlights a deep commitment to patient care that extends far beyond the initial phase of treatment. Survivorship is a critical and often overlooked aspect of the cancer journey, encompassing long-term physical, emotional, and cognitive challenges.<\/p>\n  <p>By leading this initiative, Dr. Fogh has been instrumental in creating a structured, supportive environment where survivors can access evidence-based integrative therapies to manage these long-term effects. This work involves strategic planning, collaboration with a multidisciplinary team of healthcare professionals, and a focus on improving the overall quality of life for patients. Therefore, her leadership in this area serves as a model for how health systems can effectively integrate TCIM into standard oncology care pathways, ensuring that patients are supported holistically throughout their recovery.<\/p>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Connect with Dr. Fogh<\/h3>\n  <p>To further explore the research, clinical work, and publications of Dr. <strong>Shannon Elizabeth Fogh<\/strong>, please refer to her official professional profiles. These resources offer detailed information on her contributions to the fields of radiation oncology and integrative medicine.<\/p>\n  <p>\n    <strong>Official Profile at Fred Hutch Cancer Center:<\/strong>\n    <a href=\"https:\/\/www.fredhutch.org\/en\/faculty-lab-directory\/fogh-shannon.html\" target=\"_blank\" rel=\"noopener noreferrer\">View Professional Profile<\/a>\n  <\/p>\n  <p>\n    <strong>University of Washington Medicine Profile:<\/strong>\n    <a href=\"https:\/\/radonc.uw.edu\/profile\/shannon-fogh\/\" target=\"_blank\" rel=\"noopener noreferrer\">View Faculty Profile<\/a>\n  <\/p>\n<\/div>\n<!-- \/wp:html -->","post_title":"Shannon Elizabeth Fogh","post_excerpt":"Dr. Shannon Elizabeth Fogh is a dual board-certified physician in radiation oncology and integrative medicine. Her work bridges these fields to improve outcomes and reduce treatment toxicity for cancer patients, with research focused on brain tumors, metabolic health, and the microbiome.","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"shannon-elizabeth-fogh","to_ping":"","pinged":"","post_modified":"2025-09-29 09:40:56","post_modified_gmt":"2025-09-29 12:40:56","post_content_filtered":"","post_parent":0,"guid":"https:\/\/wctcim.cabsin.org.br\/new\/speaker\/shannon-elizabeth-fogh\/","menu_order":0,"post_type":"speaker","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":5577,"post_author":"2","post_date":"2025-09-14 20:49:49","post_date_gmt":"2025-09-14 23:49:49","post_content":"<!-- wp:html -->\n<style>\n  .speaker-bio {\n    display: flex;\n    flex-wrap: wrap;\n    align-items: flex-start;\n    gap: 20px;\n  }\n\n  .speaker-bio figure {\n    width: 225px;\n    height: 225px;\n    margin: 0 20px 30px 0;\n  }\n  .speaker-bio figure img {\n    width: 100%;\n    height: 100%;\n    object-fit: cover;\n    border-radius: 50%;\n    border: none;\n  }\n\n  .bio-content {\n    flex: 1;\n    color: #414d58;\n    font-size: 15px;    \n    line-height: 1.6;\n  }\n  .bio-content a {\n    color: #1d89e4;\n    text-decoration: none;\n  }\n\n  .bio-content h2 {\n    font-size: 24px;\n    color: #1d89e4;\n    font-weight: 600;\n    line-height: 1.5;\n    margin-bottom: 1em;\n  }\n  .bio-content h3 {\n    font-size: 18px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.8em;\n    margin-bottom: 0.8em;\n  }\n  .bio-content h4 {\n    font-size: 15px;\n    color: #1d89e4;\n    font-weight: 500;\n    line-height: 1.4;\n    margin-top: 1.5em;\n    margin-bottom: 0.6em;\n  }\n\n  .speaker-separator {\n    margin: 0;\n    border: none;\n    border-top: 1px solid #ccc;\n  }\n\n  @media (max-width: 600px) {\n    .speaker-bio {\n      flex-direction: column;\n      align-items: flex-start;\n      gap: 10px;\n    }\n    .speaker-bio figure {\n      width: 180px;\n      height: 180px;\n      margin-bottom: 10px;\n    }\n    .bio-content {\n      width: 100%;\n      text-align: left;\n    }\n    .bio-content h2 {\n      font-size: 20px;\n      line-height: 1.5;\n      margin-bottom: 0.8em;\n    }\n    .bio-content h3 {\n      font-size: 16px;\n      line-height: 1.4;\n      margin-top: 1.5em;\n      margin-bottom: 0.6em;\n    }\n    .bio-content h4 {\n      font-size: 14px;\n      line-height: 1.4;\n      margin-top: 1.3em;\n      margin-bottom: 0.5em;\n    }\n    .bio-content p,\n    .bio-content ul {\n      font-size: 14px;\n    }\n  }\n<\/style>\n<div class=\"speaker-bio\">\n  <figure>\n    <img\n      src=\"https:\/\/wctcim.cabsin.org.br\/new\/wp-content\/uploads\/2025\/09\/carla_kuon_profile_2025_09_14.png\"\n      alt=\"Dr. Carla Kuon, Associate Professor of Clinical Medicine at UCSF\"\n    \/>\n  <\/figure>\n  <div class=\"bio-content\">\n    <h2>Carla Kuon, MD<\/h2>\n    <p><strong>Dr. Carla Kuon<\/strong> is an Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF) and a key physician at the UCSF Osher Center for Integrative Health. She serves as the Director of the OPTIMAL Long COVID Clinic, where she pioneers integrative approaches to complex chronic conditions. Her work bridges conventional internal medicine with evidence-based complementary therapies, focusing on integrative oncology and microbiome medicine.<\/p>\n    <p>Her clinical leadership and research directly support the 3rd WCTCIM's goal of integrating traditional and complementary medicine into global public health systems, offering valuable insights into treating post-viral syndromes.<\/p>\n    <p><strong>ORCID Profile:<\/strong>\n      <a href=\"https:\/\/orcid.org\/0000-0003-0723-3803\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/orcid.org\/0000-0003-0723-3803<\/a>\n    <\/p>\n  <\/div>\n<\/div>\n<hr class=\"speaker-separator\">\n<div class=\"bio-content\">\n  <h3>Biography and Expertise of Carla Kuon<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong> is a distinguished clinician and academic at the forefront of integrative medicine in the United States. As an Associate Professor at the University of California, San Francisco (UCSF), she has cultivated a unique career path that merges the rigors of internal medicine and hospitalist care with the holistic principles of integrative oncology and microbiome science. This dual expertise allows her to manage complex medical cases with a comprehensive toolkit that includes both conventional treatments and evidence-based complementary therapies.<\/p>\n  <p>Her work is deeply aligned with the 3rd WCTCIM's thematic axis, \"Contributions of TCIM to Global Public Health (Evidence-Based).\" Dr. Kuon's leadership of the OPTIMAL Long COVID Clinic exemplifies this, as she addresses one of the most significant public health challenges of our time through an integrative lens. Consequently, she utilizes holistic methods, including diet and nutraceuticals, to manage a condition that often eludes conventional treatment paradigms. This approach embodies the congress motto of promoting \"Knowledge Diversity\" for \"Well-being Societies.\"<\/p>\n  <p>Furthermore, the work of Dr. <strong>Carla Kuon<\/strong> in functional immunology and the management of functional gut disorders demonstrates a commitment to understanding the root causes of chronic illness. Her research and clinical practice are guided by the principles of the Gujarat Declaration, emphasizing science and evidence to validate and scale integrative health solutions. Her pioneering efforts provide a powerful model for the \"Integration of TCIM into Health Systems,\" showcasing how specialized clinics can collaborate with mainstream departments like pulmonary medicine to deliver superior patient outcomes.<\/p>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Professional Career<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong>'s career reflects a progression from a dedicated hospitalist to a leader in academic integrative medicine. She began in internal medicine, honing her skills in acute patient care. For over a decade, she served as a hospitalist, gaining experience with complex cases, including as an oncologic hospitalist on the UCSF bone marrow transplant service.<\/p>\n  <p>This clinical experience was the bedrock for her innovations. A pivotal moment was creating the inpatient hematology massage service at UCSF, a program she conceived, funded, and directs. This initiative shows her commitment to integrating patient-centered therapies to alleviate pain and anxiety. It was a step toward building institutional infrastructure for integrative care. Her career shows an evolution toward leadership roles shaping medicine's future.<\/p>\n  <ul>\n    <li><strong>2023 - Present:<\/strong> Director, OPTIMAL-IH Long COVID Clinic, UCSF, leading a nationally recognized clinic for post-viral care.<\/li>\n    <li><strong>2017 - Present:<\/strong> HS Associate Professor, Integrative Medicine, OSHER center, UCSF, where she teaches and provides clinical care.<\/li>\n    <li><strong>2017 - Present:<\/strong> Director, BMT Adult Massage Services, UCSF, overseeing a unique service for oncology patients.<\/li>\n    <li><strong>2013 - 2017:<\/strong> HS Assistant Professor, Hospitalist, Medicine, UCSF, contributing to academic hospital medicine.<\/li>\n    <li><strong>2010 - 2013:<\/strong> HS Clinical Instructor, Hospitalist, Medicine, UCSF, beginning her academic career at UCSF.<\/li>\n    <li><strong>2005 - 2013:<\/strong> Served as a Hospitalist in Internal Medicine at various institutions, including St. Helena Medical Center, TEAMHEALTH, and Galen Physicians, building a strong foundation in clinical practice.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Academic Qualifications<\/h3>\n  <p>The academic foundation of Dr. <strong>Carla Kuon<\/strong> is distinguished by its interdisciplinary nature, combining a strong background in the humanities with rigorous medical and scientific training. This unique blend provides her with a multifaceted perspective on patient care, communication, and health systems. Her education began with a Bachelor of Arts in Spanish and Portuguese Linguistics from the University of California, Los Angeles (UCLA), an experience that cultivated deep cultural and communicative competencies.<\/p>\n  <p>Following her undergraduate studies, she pursued her medical degree, residency, and a specialized fellowship that solidified her expertise in both conventional and integrative medicine. This comprehensive training pathway equipped her to not only practice medicine effectively but also to question existing paradigms and innovate new models of care. Consequently, her academic journey reflects a deliberate effort to build a skill set capable of addressing the complex, multifactorial nature of modern chronic diseases.<\/p>\n  <ul>\n    <li><strong>2018:<\/strong> Fellowship in Integrative Medicine, UCSF Osher Center, where she specialized in holistic and evidence-based complementary practices.<\/li>\n    <li><strong>2004:<\/strong> Residency in Medicine, TUFTS Medical Center, Boston, completing her postgraduate clinical training in internal medicine.<\/li>\n    <li><strong>2002:<\/strong> Internship in Medicine, TUFTS-Saint Elizabeth's Medical Center, Boston, marking her initial year of postgraduate training.<\/li>\n    <li><strong>2001:<\/strong> Doctor of Medicine (M.D.), University of Texas, San Antonio, where she earned her medical degree.<\/li>\n    <li><strong>1995:<\/strong> Bachelor of Arts (B.A.) in Spanish and Portuguese Linguistics, University of California, Los Angeles, graduating with Dean's Honors.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Research and Publications of Carla Kuon<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong> is not only a master clinician but also a dedicated scholar and author who contributes actively to the scientific literature. Her research is centered on improving patient care through integrative methods, with a significant focus on Long COVID and microbiome health. Her most prominent research involvement is as a collaborating investigator on a major grant from the National Institutes of Health (NIH) Agency for Healthcare Research and Quality (AHRQ). This five-year project aims to expand the UCSF Long COVID OPTIMAL clinic program, focusing on enhancing access and equity for underserved and minority populations.<\/p>\n  <p>This NIH-funded work is crucial because it uses an implementation science framework to scale up a successful integrative care model. It seeks to identify and overcome barriers to ensure the sustainability of comprehensive Long COVID care, directly aligning with the WHO's strategy of embedding traditional and complementary medicine into public health infrastructure. Beyond this grant, Dr. <strong>Carla Kuon<\/strong> has published articles on managing C. Difficile in oncology patients, showcasing her expertise in gut health within complex medical settings.<\/p>\n  <p>Furthermore, she translated her clinical expertise into a practical guide for the public by authoring the book, \"The Long COVID Solution,\" which outlines a holistic approach to recovery. This publication extends her impact beyond the clinic, empowering patients with knowledge and self-care strategies. Her scholarly activities demonstrate a clear commitment to building and disseminating an evidence base for integrative medicine.<\/p>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Awards and Recognitions<\/h3>\n  <p>The clinical excellence and innovative contributions of Dr. <strong>Carla Kuon<\/strong> have been formally recognized through numerous awards and honors throughout her academic and professional career. These accolades highlight her dedication to patient care, her leadership in developing new clinical programs, and her standing as a respected expert within one of the world's leading medical institutions. These recognitions underscore the impact of her work in advancing integrative medicine.<\/p>\n  <p>Her most recent honors, including a Master Clinician nomination and the UCSF Interprofessional Collaboration Award for the OPTIMAL Clinic, are particularly significant. They acknowledge not only her individual skill but also her success in fostering collaborative, team-based care models, which are essential for the successful integration of TCIM into complex healthcare systems. Consequently, these awards validate her approach and serve as an inspiration for the broader medical community.<\/p>\n  <ul>\n    <li><strong>2024:<\/strong> UCSF Interprofessional Collaboration Award, OPTIMAL Clinic, recognizing the clinic's successful multidisciplinary approach.<\/li>\n    <li><strong>2024:<\/strong> Master Clinician Nomination, acknowledging her exceptional clinical skills and patient care.<\/li>\n    <li><strong>2001:<\/strong> John Primono Humanitarian Award, University of Texas, San Antonio, highlighting her compassionate approach to medicine early in her career.<\/li>\n    <li><strong>1997:<\/strong> National Hispanic Scholarship Award, from the National Hispanic Scholarship Association.<\/li>\n    <li><strong>1995:<\/strong> Deans Honors, UCLA, for outstanding academic achievement.<\/li>\n    <li><strong>1993:<\/strong> Del Amo Scholarship and Alumni Scholarship, UCLA, recognizing her academic promise.<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Board and Committee Activities<\/h3>\n  <p>Dr. <strong>Carla Kuon<\/strong> demonstrates her commitment to advancing medicine through active participation in several leading professional organizations. Her memberships reflect her dual expertise, spanning conventional, preventative, and integrative medicine. This involvement ensures she remains at the cutting edge of developments in her fields and contributes her unique perspective to the broader medical community.<\/p>\n  <p>Her engagement with these societies is vital for fostering professional networks, shaping clinical standards, and advocating for patient-centered care. For instance, her membership in the Benioff Center for Microbiome Medicine places her within an elite group of researchers exploring one of the most exciting frontiers in science. Therefore, these activities are integral to her role as a leader and innovator.<\/p>\n  <ul>\n    <li><strong>2022 - Present:<\/strong> Member, Benioff Center for Microbiome Medicine<\/li>\n    <li><strong>2018 - Present:<\/strong> Member, American Board of Preventative Medicine<\/li>\n    <li><strong>2016 - Present:<\/strong> Member, Society of Hospital Medicine<\/li>\n    <li><strong>2008 - Present:<\/strong> Member, American Board of Internal Medicine<\/li>\n    <li><strong>2001 - Present:<\/strong> Member, American College of Physicians<\/li>\n    <li><strong>2001 - 2010:<\/strong> Member, Peruvian American Medical Society<\/li>\n  <\/ul>\n<\/div>\n<div class=\"bio-content\">\n  <h3>Connect with Dr. Kuon<\/h3>\n  <p>To further explore the work of Dr. <strong>Carla Kuon<\/strong>, including her clinical practice at the UCSF Osher Center for Integrative Health and her academic contributions, please visit her official university profiles. These resources provide detailed information on her expertise, research, and publications.<\/p>\n  <p>\n    <strong>Official Profile at UCSF Osher Center for Integrative Health:<\/strong>\n    <a href=\"https:\/\/osher.ucsf.edu\/patient-care\/our-team\/carla-kuon-md\" target=\"_blank\" rel=\"noopener noreferrer\">View Professional Profile<\/a>\n  <\/p>\n  <p>\n    <strong>Academic Profile at UCSF Profiles:<\/strong>\n    <a href=\"https:\/\/profiles.ucsf.edu\/carla.kuon\" target=\"_blank\" rel=\"noopener noreferrer\">View Academic and Research Profile<\/a>\n  <\/p>\n<\/div>\n<!-- \/wp:html -->","post_title":"Carla Kuon","post_excerpt":"Carla Kuon is an Associate Professor at UCSF and an Integrative Oncologist. She directs the NIH-funded OPTIMAL Long COVID clinic, applying holistic methods to complex conditions. Dr. Kuon authored a book on Long COVID recovery and leads research in functional immunology and microbiome medicine.","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"carla-kuon","to_ping":"","pinged":"","post_modified":"2025-09-29 06:04:07","post_modified_gmt":"2025-09-29 09:04:07","post_content_filtered":"","post_parent":0,"guid":"https:\/\/wctcim.cabsin.org.br\/new\/speaker\/carla-kuon\/","menu_order":0,"post_type":"speaker","post_mime_type":"","comment_count":"0","filter":"raw"}],"activity":{"ID":6273,"post_author":"2","post_date":"2025-09-18 18:21:54","post_date_gmt":"2025-09-18 21:21:54","post_content":"","post_title":"Workshop \u2758 The Role Of The Microbiome In Cancer","post_excerpt":"This workshop at the 3rd WCTCIM explores the intricate relationship of the Microbiome In Cancer. Participants will engage in a practical session to gain hands-on knowledge from experts on how gut health influences oncology and integrative treatment approaches for better patient outcomes.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"microbiome-in-cancer","to_ping":"","pinged":"","post_modified":"2025-10-12 20:37:08","post_modified_gmt":"2025-10-12 23:37:08","post_content_filtered":"","post_parent":0,"guid":"https:\/\/wctcim.cabsin.org.br\/new\/activity\/microbiome-in-cancer\/","menu_order":0,"post_type":"activity","post_mime_type":"","comment_count":"0","filter":"raw"}},"rank_math_fields":{"rank_math_title":"Guidelines ASCO SIO \u2758 Activity \u2758 Day 17 \u2758 3rd WCTCIM","rank_math_description":"Explore the updated Guidelines ASCO SIO for integrative oncology. Learn about the evidence-based recommendations for integrating therapies into cancer care.","rank_math_focus_keyword":"Guidelines ASCO SIO","rank_math_seo_score":"51","rank_math_canonical_url":"","rank_math_internal_links_processed":""},"global_fields":{"notion_id":null},"featured_image_url":null,"taxonomies":[{"term_id":221,"name":"Presentations","slug":"presentations","term_group":0,"term_taxonomy_id":221,"taxonomy":"activity-category","description":"A Presentation at the 3rd WCTCIM is an individual talk delivered by a speaker. It is the fundamental unit of content within a larger session, such as a Panel or Plenary, focusing on a specific topic within the session's theme.","parent":0,"count":339,"filter":"raw"},{"term_id":188,"name":"Room 6","slug":"room-6","term_group":0,"term_taxonomy_id":188,"taxonomy":"activity-location","description":"","parent":0,"count":61,"filter":"raw"}],"action":"updated","source":"manual_ui","_links":{"self":[{"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/presentation\/6340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/presentation"}],"about":[{"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/types\/presentation"}],"wp:attachment":[{"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/media?parent=6340"}],"wp:term":[{"taxonomy":"activity-category","embeddable":true,"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/activity-category?post=6340"},{"taxonomy":"activity-tag","embeddable":true,"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/activity-tag?post=6340"},{"taxonomy":"activity-location","embeddable":true,"href":"https:\/\/wctcim.cabsin.org.br\/new\/wp-json\/wp\/v2\/activity-location?post=6340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}